Smart Critical Assurance

Smart Critical Assurance is a three-tier critical-illness product with a fixed 5-year payment window and tiered payouts for multiple CI stages. Unlike single-payout CI products, it stacks Minor (50%), Intermediate (100%), and Major (100%) conditions into one policy — paying across stages only once per category, with a final endowment at policy maturity. The structural hook: a 15-year coverage window with maturity benefit (100% UP returned at age 75 or contract end) gives customers a “buy at 40, covered to 75, get your money back” promise. Simplicity is the pitch — two plans (Basic and Comprehensive), no optional riders, no premium waiver, flat 5-year premium payment.

In one line: Pay premiums for five years; your family is protected against early, intermediate, and late-stage critical illness; if nothing happens, you get your money back when the policy ends.

---

The RIPLAY case uses Andi, 40yo male, Rp 500M sum assured, Comprehensive Plan, coverage to age 75 (35 years), annual premium Rp 42.937M:

Critical insight for agent narrative: the product is mechanically simple but deliberately conservative. Unlike competitors’ 260% multi-claim scenarios, Smart Assurance caps total payouts near 250% in best-case multi-stage scenarios. The maturity benefit (100% UP return) is the only “reward” for non-claiming — it’s a structured certainty play, not a savings play.

---

Sweet Spot — Lead with Smart Critical Assurance

• Age 35–52, employed (corporate or government), household income Rp 15M+/month
• Seeking simplicity — “I want CI coverage, I don’t want to choose between 10 options”
• Moderate concern about cancer, heart disease, or stroke (from family history or age-typical risk awareness)
• Wants a maturity benefit — if nothing happens, I get my premium back by age 75. Appeals to risk-averse, discipline-oriented customers
• Comfortable with fixed payment term (5 years) — doesn’t want to think about premiums after age 45
• Not interested in optional riders — base coverage is sufficient
• Already has health insurance elsewhere; this is the CI layer only
• Target income: Rp 15M–40M/month (middle-affluent, not mass-market)

Borderline Fit — Qualify carefully

• Age 53–60 — premium loads; coverage end age capped at 75. Product still works but is expensive relative to simpler alternatives. Lead with Basic Plan (fewer conditions, lower cost).
• Young (under 35) with high income — product has overhead (maturity benefit structure); younger customers may want cheaper standalone CI. Defer if they’re purely cost-driven.
• Self-employed with volatile income — 5-year payment commitment is high if income drops. Good fit only if cashflow is stable.
• Existing MSIG policyholder — check for overlap with their existing CI or whole-life provisions; Smart Assurance should fill a gap, not duplicate.

Do Not Pitch

• Mass middle market (household income <Rp 10M/month) — Rp 42.937M annual premium is prohibitive; minimum SA is Rp 150M, making per-month cost unsustainable
• Customers seeking investment upside or flexible payouts — product is pure protection with structural return (maturity benefit); no UL component
• Prospects with serious pre-existing condition — underwriting is strict; exclusion list is long (AIDS, pre-existing, congenital, self-harm, substance abuse)
• Anyone wanting flexible premium terms — 5-year fixed is non-negotiable; no annual-pay-only options
• Customers already holding comprehensive standalone CI elsewhere — “more CI” creates lapse risk; only pitch if there’s a clear gap (age, condition count, benefit staging)

---

Rule of thumb: Smart Assurance wins on three criteria: (1) Simplicity (no rider decisions), (2) Maturity refund (non-claimers get 100% UP back), and (3) Fixed certainty (premium locked 5 years, coverage to 75). If the customer’s priority is any of those three, it’s a natural fit. If they prioritize cost, multiple-claim upside, or long-tail coverage (past 75), competitors are stronger.

---

Drawn from RIPLAY and brochure analysis against 23 competitor PDFs. The Indonesian critical-illness category spans comprehensive lump-sum products (Allianz Critical Plus, AIA Vital Care), early-stage add-ons (TMLI CI Guard), gender-specific products (Prulady), and recurring-payment products (Sehat Seratus). Quantitative benchmarking is limited; qualitative assessment below.

Confidence note: structural-dimension claims are high-confidence (direct from RIPLAY/brochure); premium claims are medium-confidence (one sample rate; age/gender variation unknown); competitor-comparison claims are medium-confidence (benchmarked against 23 competitor PDFs without full financial data). Refresh trigger: when critical-illness category PDF coverage exceeds 60%, re-run quantitative benchmarking on premium elasticity (age, gender, term-length curves) and claims-payout ratios.

---

Opening — position as the “simple choice”

“Most critical-illness products on the market make you choose between 10 plans, add-on riders, and different payment structures. That complexity costs time and confidence. Smart Critical Assurance does the opposite: two plans, fixed payment for five years, then you’re done. If something happens, we pay. If nothing happens, you get your money back at 75.”

“Kebanyakan produk asuransi penyakit kritis di pasar membuat Anda memilih antara 10 plan, rider tambahan, dan struktur pembayaran berbeda. Kompleksitas itu membuang waktu dan mengurangi kepercayaan. Smart Critical Assurance melakukan kebalikannya: dua plan, pembayaran tetap selama lima tahun, setelah itu selesai. Kalau ada yang terjadi, kami bayar. Kalau tidak ada, Anda dapat uang Anda kembali di usia 75.”

The maturity benefit close (differentiator)

“Here’s what’s unusual. Most CI products: you pay premiums, hope nothing happens, and if nothing happens, the money is gone. Smart Assurance: you pay premiums for five years, if you stay healthy to age 75, you get 100% of your sum assured back. That’s Rp 500 million back in your pocket. It’s a heads-I-win, tails-I-win structure.”

“Ini yang luar biasa. Kebanyakan produk CI: Anda bayar premi, berharap tidak ada yang terjadi, dan kalau tidak ada, uangnya hilang. Smart Assurance: Anda bayar premi lima tahun, kalau Anda sehat sampai usia 75, Anda dapat 100% uang pertanggungan kembali. Itu Rp 500 juta kembali di kantong Anda. Ini struktur menang-menang.”

The three-tier payout narrative

“We cover three stages of critical illness in one policy. Early-stage cancer or early heart disease — we pay 50%. If it’s intermediate, like moderate heart blockage or specific organ issues, we pay the full amount less whatever we paid for early. If it’s major — metastatic cancer, transplant-stage heart disease — we pay 100% of what’s left. One policy, three safety nets.”

“Kami cover tiga tahap penyakit kritis dalam satu polis. Kanker stadium awal atau penyakit jantung awal — kami bayar 50%. Kalau intermediate, seperti penyumbatan jantung sedang atau masalah organ tertentu, kami bayar penuh dikurangi yang sudah kami bayar untuk tahap awal. Kalau major — kanker metastasis, penyakit jantung tahap transplantasi — kami bayar 100% dari sisa. Satu polis, tiga jaring keselamatan.”

The premium certainty pitch

“You pay premiums for five years. After year five, the policy is fully paid up. You don’t think about premiums again. If your business is struggling at year six, or your income dropped, your protection keeps going — at zero cost. That’s the point: lock in your obligation when you’re in your peak earning years, then protect your family for free from age 45 to 75.”

“Anda bayar premi selama lima tahun. Setelah tahun kelima, polis fully paid up. Anda tidak pikir soal premi lagi. Kalau bisnis Anda kesulitan di tahun enam, atau penghasilan turun, perlindungan tetap berjalan — tanpa biaya. Itu intinya: kunci komitmen saat Anda di tahun-tahun penghasilan puncak, lalu lindungi keluarga gratis dari usia 45 sampai 75.”

—

1. “Why is this so expensive compared to basic CI I saw elsewhere?”

Customer “Kenapa ini mahal sekali dibanding asuransi penyakit kritis dasar yang saya lihat di tempat lain?”

Don't say “It’s not expensive; you get what you pay for.” — dismissive of legitimate price comparison.

Don't say “Tidak mahal; Anda dapat apa yang Anda bayar.”

Do say “Fair question. You’re probably comparing to basic CI that costs Rp 500k/year for Rp 500M coverage. We’re Rp 42.9M/year. The difference is twofold: first, we cover three stages of illness (early, intermediate, major), not just one. Second — and this is the big one — if you stay healthy and never claim, you get your entire sum assured back at age 75. That’s Rp 500 million back to your family or estate. Competitors’ Rp 500k product has zero maturity benefit. You’re not just buying CI; you’re buying a forced savings plan with CI on top. The price reflects that.”

Do say “Pertanyaan fair. Kemungkinan Anda bandingkan dengan CI dasar yang harga Rp 500k/tahun untuk coverage Rp 500M. Kami Rp 42.9M/tahun. Perbedaannya dua hal: pertama, kami cover tiga tahap penyakit (awal, menengah, major), bukan satu. Kedua — dan ini yang besar — kalau Anda tetap sehat dan tidak klaim, Anda dapat seluruh uang pertanggungan kembali di usia 75. Itu Rp 500 juta kembali ke keluarga atau warisan. Produk Rp 500k kompetitor tidak ada manfaat maturity. Anda tidak hanya beli CI; Anda beli forced savings plan dengan CI di atasnya. Harga mencerminkan itu.”

—

2. “What if I get diagnosed with early cancer in year two? I still have to pay premiums?”

Customer “Bagaimana kalau saya didiagnosis kanker stadium awal di tahun kedua? Saya masih harus bayar premi?”

Don't say “Yes, it’s in the policy.” — correct but tone-deaf to the legitimate concern.

Don't say “Ya, ada di polis.”

Do say “Yes, you do — and that’s a real concern worth thinking about. Here’s the structure: you get a 50% benefit payout if early-stage cancer is diagnosed. That’s Rp 250 million. You still owe three more years of premium (Rp 128.8M total remaining). But you have the Rp 250M in hand to help cover treatment, and the family has peace of mind that if you were to pass away during those remaining three years, the remaining death benefit still pays. Most customers find the trade-off acceptable — you get paid early to manage the medical burden, and the remaining premium commitment feels manageable against the benefit cushion. But if predictable cash flow matters to you, this is a legitimate question to take seriously. Some customers choose standalone CI without the maturity benefit because it’s cheaper and has premium waiver built in.”

Do say “Ya, Anda tetap — dan itu kekhawatiran real yang layak dipikirkan. Ini strukturnya: Anda dapat benefit payout 50% kalau kanker stadium awal didiagnosis. Itu Rp 250 juta. Anda masih hutang tiga tahun premi (Rp 128.8M total sisa). Tapi Anda punya Rp 250M di tangan untuk cover pengobatan, dan keluarga punya peace of mind kalau Anda pass away di tiga tahun sisa, death benefit tetap bayar. Kebanyakan pelanggan temukan trade-off acceptable — Anda dapat bayar awal untuk manage beban medis, dan sisa komitmen premi terasa manageable terhadap benefit cushion. Tapi kalau cash flow predictable penting untuk Anda, ini pertanyaan legitimate untuk dipikirkan serius. Beberapa pelanggan pilih standalone CI tanpa maturity benefit karena lebih murah dan punya premium waiver built-in.”

—

3. “I don’t understand the ‘three tiers’ — how do the payouts actually work?”

Customer “Saya tidak paham ‘tiga tingkat’ — bagaimana pembayaran sebenarnya bekerja?”

Don't say “It’s explained in the RIPLAY.” — unhelpful; RIPLAY is complex.

Don't say “Dijelaskan di RIPLAY.”

Do say “Let me walk you through the example from the product brochure. Andi, age 40, Rp 500M coverage. At 50, he’s diagnosed with Carcinoma In Situ, which is Early-stage cancer (Minor tier). The policy pays 50% of Rp 500M = Rp 250M. Now his remaining benefit pool is Rp 250M. At 55, he’s diagnosed with Moderate Heart Disease (Intermediate tier). The policy pays 100% of the remaining pool = Rp 250M. His benefit pool is now zero. Policy ends. Total he received: Rp 500M. He paid Rp 214.685M in premiums over five years. Return: 2.33x his premium. The point: you can get paid at multiple stages, but the total pie is fixed at your sum assured. Each claim reduces the pool for the next one. Once Major CI happens, it’s 100% of whatever’s left and the policy terminates.”

Do say “Mari saya jalani contoh dari brochur produk. Andi, usia 40, coverage Rp 500M. Di usia 50, dia didiagnosis Carcinoma In Situ, yang Kanker stadium awal (tier Minor). Polis bayar 50% dari Rp 500M = Rp 250M. Sekarang pool benefit sisanya Rp 250M. Di usia 55, dia didiagnosis Penyakit Jantung Sedang (tier Intermediate). Polis bayar 100% dari pool sisa = Rp 250M. Pool benefit dia sekarang nol. Polis berakhir. Total dia dapat: Rp 500M. Dia bayar Rp 214.685M premi dalam lima tahun. Return: 2.33x premium dia. Poinnya: Anda bisa dapat bayar di tahap berlapis, tapi total pie tetap fix di uang pertanggungan Anda. Tiap klaim kurangi pool untuk yang berikutnya. Begitu Major CI terjadi, itu 100% dari apapun sisanya dan polis terminate.”

—

4. “My family history has early cancer. Should I get Comprehensive or Basic?”

Customer “Riwayat keluarga saya ada kanker stadium awal. Saya harus ambil Comprehensive atau Basic?”

Don't say “Comprehensive covers more conditions, so Comprehensive.” — upsell reflex, not analytic.

Don't say “Comprehensive cover lebih banyak kondisi, jadi Comprehensive.”

Do say “The key difference: Comprehensive covers 14 Intermediate conditions; Basic does not. If your family history is specifically early-stage cancer (carcinoma in situ, treatable breast or cervical cancer), then Basic covers those under the Minor tier and will pay 50%. Comprehensive doesn’t pay more for those — it still pays 50% for Minor. The value-add in Comprehensive is if you’re concerned about Intermediate conditions like moderate heart disease or moderate liver cirrhosis. If your concern is purely ‘early cancer picked up at regular screening,’ Basic is sufficient and cheaper. If you worry about a broader range of organ issues, Comprehensive makes sense. What specific conditions worry you most in your family history?”

Do say “Perbedaan kunci: Comprehensive cover 14 kondisi Intermediate; Basic tidak. Kalau riwayat keluarga Anda specifically kanker stadium awal (carcinoma in situ, breast atau cervical cancer treatable), Basic cover itu di tier Minor dan akan bayar 50%. Comprehensive tidak bayar lebih untuk itu — tetap bayar 50% untuk Minor. Value-add di Comprehensive kalau Anda khawatir kondisi Intermediate seperti penyakit jantung moderate atau liver cirrhosis moderate. Kalau kekhawatiran Anda purely ‘early cancer picked up saat screening rutin,’ Basic cukup dan lebih murah. Kalau Anda khawatir range lebih luas organ issues, Comprehensive make sense. Kondisi apa yang paling Anda khawatirkan di riwayat keluarga Anda?”

—

5. “What happens if I stop paying premiums after year three?”

Customer “Apa yang terjadi kalau saya berhenti bayar premi setelah tahun ketiga?”

Don't say “The policy lapses.” — correct but doesn’t address the implicit question (what’s my protection?).

Don't say “Polis lapse.”

Do say “If you stop paying in year three and have paid-in Rp 128.8M of the total Rp 214.685M, here’s what happens: your policy lapses. You lose protection immediately. If you had claimed for early-stage CI in year one, you’d have Rp 250M in hand plus a policy that keeps running even if you lapse — the protection is already purchased and paid for. But if you haven’t claimed and you miss a payment, the coverage stops. You also forfeit the maturity benefit — you won’t get the Rp 500M back at 75 because the policy is no longer active. This is why the 5-year commitment matters: it’s designed to work best if you complete the payment cycle. If you know your cash flow is uncertain, be realistic about whether you can commit to five years. Many customers choose annual payment (instead of monthly) to make the commitment feel more conscious — a yearly ‘yes, I commit’ rather than 12 small monthly withdrawals.”

Do say “Kalau Anda berhenti bayar di tahun ketiga dan sudah bayar-in Rp 128.8M dari total Rp 214.685M, ini yang terjadi: polis Anda lapse. Anda kehilangan perlindungan immediately. Kalau Anda sudah klaim untuk CI stadium awal di tahun pertama, Anda punya Rp 250M di tangan plus polis yang tetap running bahkan kalau Anda lapse — perlindungan sudah purchased dan paid for. Tapi kalau Anda belum klaim dan miss payment, coverage berhenti. Anda juga forfeit maturity benefit — Anda tidak dapat Rp 500M di usia 75 karena polis tidak aktif lagi. Ini kenapa 5-tahun commitment penting: didesain untuk work best kalau Anda complete payment cycle. Kalau Anda tahu cash flow Anda uncertain, realistis soal apakah Anda bisa commit lima tahun. Banyak pelanggan pilih annual payment (instead of monthly) untuk make the commitment terasa lebih conscious — tahunan ‘ya, saya commit’ daripada 12 small monthly withdrawals.”

—

These issues carry the highest risk of OJK complaints and customer churn under POJK 36/2025 (conduct of business) and POJK 81/2016 (product governance).

1. Overstating condition count as “comprehensive coverage.” Saying “149 conditions means broader coverage than competitors” is misleading. The 149 figure includes stage variants (same disease listed three times: Early, Intermediate, Major). Actual disease taxonomy is ~40–50 unique conditions. Marketing should emphasize “three-stage coverage” and “early, intermediate, major protection,” not “149 conditions.” Always clarify: “These are grouped by severity, not by disease count.” POJK 36/2025 requires honest condition disclosure; inflating via stage-counting violates transparency.

2. Misrepresenting the maturity benefit as “free money.” Customers sometimes interpret “get your sum assured back” as pure profit. It’s not; it’s a return of their own premium + mortality cost + admin fee. Clarify: “The maturity benefit is 100% of your sum assured if you reach age 75 with no Major CI claim. You’ve paid Rp 214.685M in premiums; you receive Rp 500M. The gap is funded by the pooled premiums of customers who claimed earlier. It’s not a gift — it’s your share of the mutual pool if you were lucky enough not to need it.” Overstating this as “free Rp 500M” creates expectation mismatch and complaint risk.

3. Unclear payout sequencing and the “shared pool” logic. The three-tier payout mechanism (Minor takes 50%, Intermediate takes 100% of remainder, Major takes 100% of final remainder) is the product’s defining complexity. Agents often fail to explain that the UP is a shared, depleting pool, not three separate benefit pockets. If an agent says “you get 50% for early cancer AND 100% for intermediate cancer” without clarifying that the 100% comes from what’s left after the 50%, customers will claim violation when they realize the actual benefit is Rp 250M (50% + 50% remainder), not Rp 750M (50% + 100% + 100%). Always show the worked example from the RIPLAY. Always walk the customer through a multi-claim scenario. Document the customer’s understanding on the SPAJ.

4. Premium payment commitment without lapse-consequence clarity. The 5-year commitment is fixed; there is no grace period, no flexible deferral, no payment holiday option. If a customer misses month 13, the entire policy lapses and maturity benefit is forfeited. Agents sometimes soft-sell this (“it’s just five years of payments”) without hammering the consequence. If the customer’s employment situation is shaky, or if they have income volatility (seasonal business, commission-based pay), they should seriously reconsider or choose a level-to-age competitor product instead. Document the customer’s employment stability and cash-flow certainty on the medical form before underwriting.

5. Pre-existing condition exclusion and the 90-day waiting period. MSIG’s exclusion list is long and includes pre-existing conditions. If a customer had a doctor’s appointment for chest pain 60 days before inception, and they have an MI diagnosis at day 95, the claim is denied (waiting period block) AND they are flagged for mis-disclosure if they failed to report the doctor visit on the SPAJ. This is the highest complaint risk for this product. Always ask: “In the last 12 months, have you had any doctor visits, lab tests, or diagnoses for heart, lung, liver, kidney, cancer, or stroke-related symptoms?” If the customer hesitates or says “I had a checkup but it was normal,” escalate to medical underwriting. Do not rush the SPAJ.

6. Misrepresenting maturity benefit as compound growth. Some agents compare Smart Assurance to investment products: “You pay Rp 214.685M, you get Rp 500M at 75, that’s 7.5% compound annual growth.” This is misleading. The maturity benefit is a fixed return of sum assured (100%), not a growth product. Premium remains the same; benefit is locked in. If the customer is seeking investment returns or inflation-hedging growth, they should be in a unit-linked product or investment insurance, not Pure Protection CI. Using growth language creates false positioning and regulatory risk.

7. Treating “no premium waiver” as minor feature omission. Unlike Allianz Flexi CI (which includes CI premium waiver), Smart Assurance has no waiver. If a customer is diagnosed with early-stage cancer in year two and must pay three more years of premium (Rp 128.8M) while managing treatment costs, lapse risk is extreme. Agents should NOT downplay this (“most people can handle three more years of payments”). Instead, own the weakness: “We don’t have premium waiver built in. If you’re concerned about payment sustainability post-diagnosis, you should know that competitors like Allianz include a premium waiver as standard. That’s a real difference. Let me explain how to plan for that risk.” Honesty here prevents post-claim complaints.

8. Compliance with POJK 36/2025 suitability assessment. POJK 36/2025 requires agents to assess customer financial situation, needs, and suitability before recommending. Smart Assurance’s Rp 42.937M annual premium is significant. If a customer’s monthly income is Rp 15M and total insurance commitments (health, auto, life) are already Rp 5M/month, Smart Assurance at Rp 3.6M/month (or Rp 8.4M quarterly) may trigger over-insurance concerns. Always complete a suitability checklist: gross monthly income, existing commitments, discretionary budget post-insurance. Document this. If suitability is marginal, discuss Basic Plan (lower cost) or recommend deferral until income rises.

---

---

1. Build a one-page comparison: Smart Assurance vs. Allianz Flexi CI vs. standalone basic CI. Create a grid (EN + ID) showing: plan cost, condition count, maturity benefit, premium waiver, payment term, flexibility. This is agents’ most common confusion point — they need a visual to see why Smart Assurance is expensive but unique, and when a cheaper competitor makes sense. Mobile-friendly PDF.

2. Develop an explainer on the “shared benefit pool” payout logic. Agents misunderstand (or poorly explain) why early CI + intermediate CI claims don’t pay Rp 750M (50% + 100%) but rather Rp 500M (50% + 50% remainder). Create a visual flowchart (using the RIPLAY example) that traces the UP depletion. One A4 sheet, agent-shareable.

3. Create a cash-flow stress-test framework for agents. Before pitching Smart Assurance, agents should ask: “Can this customer sustain Rp 42.937M/year for five years even if income drops 30%?” Build a simple monthly-budget calculator (or checklist) that agents can use during discovery. If suitability is marginal, agents should recommend Basic Plan (lower cost) or defer.

4. Audit Legacy Income’s current Smart Assurance lapse rate (if any policies in force). Compare to Allianz and standalone CI lapse rates in the portfolio. If Smart Assurance lapses are higher, the root cause is likely cash-flow pressure post-year-2 or post-diagnosis premium shock. Use audit to refine agent messaging (emphasize pre-diagnosis commitment) and positioning (tighten qualification on income stability).

5. Schedule an underwriting deep-dive with MSIG on pre-existing-condition handling and 90-day waiting period. Smart Assurance’s highest complaint risk is borderline pre-existing cases (customer had a doctor visit for vague symptoms 60 days pre-inception, then diagnosed with CI at day 95). Get MSIG’s exact protocol, case examples, and the SPAJ question sequence. Build Legacy Income’s agent checklist around it.

6. Prepare a “maturity benefit” education piece for mass-affluent prospects. This feature is unique and marketable but often oversold or misunderstood. Create a one-page explainer (EN + ID): "What it is (100% UP return if no Major CI claim to age 75), what it costs (embedded in premium), what it’s not (not a growth product, not tax-free, not inflation-adjusted). Target use: send to prospects before first meeting to set realistic expectations.

---